Reuters: Ranbaxy may use M&A to grow in Japan generics market

[chris]

Ranbaxy may use M&A to grow in Japan generics market
      

TOKYO (Reuters) - India's Ranbaxy Laboratories Ltd  sees tremendous opportunities for growth in Japan's generics drug market and mergers and acquisitions are a likely option for it to expand, its chief executive said on Thursday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login